Aspirin therapy in nonarteritic anterior ischemic optic neuropathy

American Journal of Ophthalmology
R W BeckP S Moke

Abstract

To determine the benefit of aspirin in reducing the risk of nonarteritic anterior ischemic optic neuropathy in the fellow eye following its occurrence in the first eye. A retrospective cohort study was conducted on 431 patients, 153 of whom were and 278 of whom were not prescribed aspirin following the development of unilateral nonarteritic anterior ischemic optic neuropathy. The 2-year cumulative probability of nonarteritic anterior ischemic optic neuropathy in the fellow eye was 7% in the aspirin group and 15% in the no-aspirin group, and 5-year cumulative probabilities were 17% and 20%, respectively. Compared with the no-aspirin group, the rate ratio for nonarteritic anterior ischemic optic neuropathy in the fellow eye in the aspirin-user group was 0.43 (95% confidence interval, 0.19 to 0.92) over the first 2 years and 0.68 (95% confidence interval, 0.36 to 1.26) over the 5-year period. The overall calculated 5-year risk was 19%; however, if none of the patients with incomplete follow-up developed nonarteritic anterior ischemic optic neuropathy in the fellow eye, then the 5-year risk would be about 12%. The 5-year risk of nonarteritic anterior ischemic optic neuropathy occurring in the second eye is far lower than that repor...Continue Reading

References

Oct 1, 1983·American Journal of Ophthalmology·M X RepkaR C Sergott
Dec 15, 1994·American Journal of Ophthalmology·S S HayrehC R Long

❮ Previous
Next ❯

Citations

Oct 2, 2008·Neurological Research·Geetha AthappillyJeffrey L Bennett
Nov 2, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Corina RadoiCarl Arndt
Jan 31, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Christoph KernstockUlrich Schiefer
Dec 3, 2014·Indian Journal of Ophthalmology·Sohan Singh Hayreh
Mar 12, 2003·Current Rheumatology Reports·J Banks Shepherd
Oct 3, 2001·Ophthalmology·S S Hayreh
Nov 11, 2010·Current Treatment Options in Neurology·Edward J Atkins
Mar 10, 2004·The Journal of Laboratory and Clinical Medicine·Charles J GlueckNaila Goldenberg
Sep 5, 2002·American Journal of Ophthalmology·Nancy J NewmanUNKNOWN Ischemic Optic Neuropathy Decompression Trial Research Group
Mar 23, 2006·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·T NessD Schmidt
Apr 19, 2005·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Valeria NagyGyorgy Pfliegler
May 5, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Jost B JonasGangolf Sauder
Apr 12, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sohan Singh Hayreh, M Bridget Zimmerman
Jul 1, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sohan Singh HayrehDaniel M Jacobson
Oct 30, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sohan Singh Hayreh
Dec 5, 2008·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Barbara GiambeneUgo Menchini
Nov 17, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sohan Singh Hayreh
Apr 25, 2012·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Sohan Singh Hayreh
Aug 19, 2005·Revue neurologique·V Biousse
Mar 7, 2007·Journal of the Chinese Medical Association : JCMA·Muh-Chiou LinShwu-Jiuan Sheu
Nov 3, 2010·Optometry : Journal of the American Optometric Association·Kiersten NelsonDax Gay
Dec 17, 2009·Survey of Ophthalmology·Edward J AtkinsValérie Biousse
Jul 15, 2009·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Nathan M KerrHelen V Danesh-Meyer
Dec 10, 2008·Progress in Retinal and Eye Research·Sohan Singh Hayreh
Sep 15, 2007·American Journal of Ophthalmology·Pisit PreechawatValérie Biousse
Mar 10, 2016·Seminars in Ophthalmology·Crandall Peeler, Dean M Cestari
Apr 3, 2007·Ophthalmology·Sohan Singh HayrehM Bridget Zimmerman
Nov 13, 2001·American Journal of Ophthalmology·S S HayrehB Zimmerman
Feb 18, 2012·Survey of Ophthalmology·Nieraj JainPrithvi Mruthyunjaya
Mar 8, 2000·American Journal of Ophthalmology·L N JohnsonR W Madsen
Dec 17, 2016·American Journal of Ophthalmology·Ahmadreza MoradiNeil R Miller
Jul 9, 2009·Ocular Immunology and Inflammation·Yi-Hsuan WeiJieh-Ren Jou
Apr 24, 2001·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·A C Arnold, A G Lee
Apr 20, 2004·Current Opinion in Neurology·Janet C RuckerNancy J Newman
Feb 5, 2013·Neuroepidemiology·Gad Dotan, Amos D Korczyn
Nov 15, 2008·The Neurologist·Katie LuneauValérie Biousse
Nov 26, 2010·Current Opinion in Neurology·Sohan Singh Hayreh
Jul 9, 2009·International Ophthalmology Clinics·Derek W DelMonte, M Tariq Bhatti
Aug 11, 2010·Seminars in Ophthalmology·Alberto Gonzalez-GarciaThomas R Hedges
Sep 24, 2013·Neuro-ophthalmology·Fatih C GundoganGungor Sobaci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.